{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:13:25Z","timestamp":1786979605038,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00066-025-02411-1","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T08:38:54Z","timestamp":1747039134000},"page":"647-652","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Proton therapy in young breast cancer patients with germline TP53 and ATM mutations: a\u00a0case series"],"prefix":"10.1007","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8863-8110","authenticated-orcid":false,"given":"Pierre","family":"Loap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid","family":"Goudjil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"de Marzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Dendale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youlia","family":"Kirova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"issue":"9804","key":"2411_CR1","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","volume":"378","author":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG), Darby S, McGale P, Correa C, Taylor C, Arriagada R,","year":"2011","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG), Darby S, McGale P, Correa C, Taylor C, Arriagada R, et\u00a0al (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378(9804):1707\u20131716","journal-title":"Lancet"},{"issue":"9935","key":"2411_CR2","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","volume":"383","author":"P McGale","year":"2014","unstructured":"EBCTCG (Early Breast Cancer Trialists\u2019 Collaborative Group), McGale\u00a0P, Taylor\u00a0C, Correa\u00a0C, Cutter\u00a0D, Duane\u00a0F,, McGale\u00a0P, Taylor\u00a0C, Correa\u00a0C, Cutter\u00a0D, Duane\u00a0F et\u00a0al (2014) Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 383(9935):2127\u20132135","journal-title":"Lancet"},{"issue":"6","key":"2411_CR3","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/bjc.1990.193","volume":"61","author":"LE Rutqvist","year":"1990","unstructured":"Rutqvist\u00a0LE, Johansson\u00a0H (1990) Mortality by laterality of the primary tumour among 55,000 breast cancer patients from the Swedish Cancer Registry. Br J Cancer 61(6):866\u2013868 (Jun)","journal-title":"Br J Cancer"},{"key":"2411_CR4","doi-asserted-by":"publisher","first-page":"103121","DOI":"10.1016\/j.critrevonc.2020.103121","volume":"156","author":"P Loap","year":"2020","unstructured":"Loap\u00a0P, Kirov\u00a0K, Kirova\u00a0Y (2020) Cardiotoxicity in breast cancer patients treated with radiation therapy: from evidences to controversies. Crit Rev Oncol Hematol 156:103121","journal-title":"Crit Rev Oncol Hematol"},{"key":"2411_CR5","doi-asserted-by":"publisher","first-page":"103574","DOI":"10.1016\/j.critrevonc.2021.103574","volume":"169","author":"P Loap","year":"2022","unstructured":"Loap\u00a0P, De Marzi\u00a0L, Almeida\u00a0CE, Barcellini\u00a0A, Bradley\u00a0J, de Santis\u00a0MC et\u00a0al (2022) Hadrontherapy techniques for breast cancer. Crit Rev Oncol Hematol 169:103574","journal-title":"Crit Rev Oncol Hematol"},{"key":"2411_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fonc.2018.00087","volume":"8","author":"C Bergom","year":"2018","unstructured":"Bergom\u00a0C, Currey\u00a0A, Desai\u00a0N, Tai\u00a0A, Strauss\u00a0JB (2018) Deep Inspiration Breath Hold: Techniques and Advantages for Cardiac Sparing During Breast Cancer Irradiation. Front Oncol 8:87","journal-title":"Front Oncol"},{"issue":"2","key":"2411_CR7","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1080\/0284186X.2023.2177976","volume":"62","author":"P Loap","year":"2023","unstructured":"Loap\u00a0P, Vu-Bezin\u00a0J, Monceau\u00a0V, Jacob\u00a0S, Fourquet\u00a0A, Kirova\u00a0Y (2023) Dosimetric evaluation of the benefit of deep inspiration breath hold (DIBH) for locoregional irradiation of right breast cancer with volumetric modulated arctherapy (VMAT). Acta Oncol 62(2):150\u2013158","journal-title":"Acta Oncol"},{"key":"2411_CR8","doi-asserted-by":"crossref","unstructured":"Loap P, Beddok A, Cao KI, Goudjil F, Fourquet A, Dendale R et\u00a0al (2021) Clinical practice of breast cancer protontherapy: A\u00a0single-centre experience from selection to treatment. Cancer Radiother 3:","DOI":"10.1016\/j.canrad.2021.01.005"},{"key":"2411_CR9","unstructured":"Vega RBM, Mohammadi H, Patel SH, Md ALH, Lockney NA, Lynch JW et\u00a0al (2021) Establishing cost-effective allocation of proton therapy for patients with mediastinal Hodgkin lymphoma. International Journal of Radiation Oncology*Biology*Physics. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0360301621026249 (Created Aug). Accessed 20 Aug 2021"},{"issue":"1","key":"2411_CR10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/jmrs.416","volume":"68","author":"AM Austin","year":"2021","unstructured":"Austin\u00a0AM, Douglass\u00a0MJJ, Nguyen\u00a0GT, Cunningham\u00a0L, Le\u00a0H, Hu\u00a0Y et\u00a0al (2021) Individualised selection of left-sided breast cancer patients for proton therapy based on cost-effectiveness. J\u00a0Med Radiat Sci 68(1):44\u201351 (Mar)","journal-title":"J Med Radiat Sci"},{"issue":"3","key":"2411_CR11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0167-8140(96)01806-3","volume":"1;40","author":"RG Bristow","year":"1996","unstructured":"Bristow\u00a0RG, Benchimol\u00a0S, Hill\u00a0RP (1996) The p53 gene as a\u00a0modifier of intrinsic radiosensitivity: implications for radiotherapy. Radiother Oncol 1;40(3):197\u2013223 (Sep)","journal-title":"Radiother Oncol"},{"issue":"Suppl\u00a01","key":"2411_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/bcr185","volume":"2","author":"J Hall","year":"2000","unstructured":"Hall\u00a0J, Ang\u00e8le\u00a0S, Vuillaume\u00a0M, G\u00e9rard\u00a0JP, Romestaing\u00a0P (2000) Role of the ATM gene in radiation sensitivity, relevance to breast cancer treatment. Breast Cancer Res 2(Suppl\u00a01):24","journal-title":"Breast Cancer Res"},{"issue":"4","key":"2411_CR13","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.ijrobp.2024.01.204","volume":"119","author":"V Petry","year":"2024","unstructured":"Petry\u00a0V, Bonadio\u00a0RC, Moutinho\u00a0K, Leite\u00a0LS, Testa\u00a0L, Cohn\u00a0DJBH et\u00a0al (2024) Frequency of Radiation Therapy-Induced Malignancies in Patients With Li-Fraumeni Syndrome and Early-Stage Breast Cancer and the Influence of Radiation Therapy Technique. Int J Radiat Oncol 119(4):1086\u20131091 (Jul)","journal-title":"Int J Radiat Oncol"},{"issue":"12","key":"2411_CR14","doi-asserted-by":"publisher","first-page":"e562","DOI":"10.1016\/S1470-2045(21)00425-3","volume":"22","author":"J Thariat","year":"2021","unstructured":"Thariat\u00a0J, Chevalier\u00a0F, Orbach\u00a0D, Ollivier\u00a0L, Marcy\u00a0PY, Corradini\u00a0N et\u00a0al (2021) Avoidance or adaptation of radiotherapy in patients with cancer with Li-Fraumeni and heritable TP53-related cancer syndromes. Lancet Oncol 22(12):e562\u201374 (Dec)","journal-title":"Lancet Oncol"},{"key":"2411_CR15","doi-asserted-by":"crossref","unstructured":"Loap P, Tkatchenko N, Goudjil F, Ribeiro M, Baron B, Fourquet A et\u00a0al (2021) Cardiac substructure exposure in breast radiotherapy: a\u00a0comparison between intensity modulated proton therapy and volumetric modulated arc therapy. Acta Oncol: 1\u20137","DOI":"10.1080\/0284186X.2021.1907860"},{"issue":"1","key":"2411_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.14338\/IJPT-22-00038.1","volume":"10","author":"P Loap","year":"2023","unstructured":"Loap\u00a0P, Goudjil\u00a0F, Servois\u00a0V, Kirov\u00a0K, Fourquet\u00a0A, Kirova\u00a0Y (2023) Radiation exposure of cardiac conduction nodes during breast proton therapy. Int J Part Ther 10(1):59\u201364","journal-title":"Int J Part Ther"},{"issue":"10","key":"2411_CR17","doi-asserted-by":"publisher","first-page":"e025556","DOI":"10.1136\/bmjopen-2018-025556","volume":"9","author":"JE Bekelman","year":"2019","unstructured":"Bekelman\u00a0JE, Lu\u00a0H, Pugh\u00a0S, Baker\u00a0K, Berg\u00a0CD, de Gonzalez\u00a0AB et\u00a0al (2019) Pragmatic randomised clinical trial of proton versus photon therapy for patients with non-metastatic breast cancer: the Radiotherapy Comparative Effectiveness (RadComp) Consortium trial protocol. Bmj Open 9(10):e25556","journal-title":"Bmj Open"},{"issue":"27","key":"2411_CR18","first-page":"126","volume":"1","author":"LB Stick","year":"2021","unstructured":"Stick\u00a0LB, Lorenzen\u00a0EL, Yates\u00a0ES, Anandadas\u00a0C, Andersen\u00a0K, Aristei\u00a0C et\u00a0al (2021) Selection criteria for early breast cancer patients in the DBCG proton trial\u2014the randomised phase\u00a0III trial strategy. Clinical and translational radiation. Oncology 1(27):126\u2013131","journal-title":"Oncology"},{"key":"2411_CR19","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.radonc.2020.05.035","volume":"149","author":"H Paganetti","year":"2020","unstructured":"Paganetti\u00a0H, Depauw\u00a0N, Johnson\u00a0A, Forman\u00a0RB, Lau\u00a0J, Jimenez\u00a0R (2020) The risk for developing a\u00a0secondary cancer after breast radiation therapy: Comparison of photon and proton techniques. Radiother Oncol 149:212\u2013218 (Aug)","journal-title":"Radiother Oncol"},{"issue":"7","key":"2411_CR20","first-page":"e1458","volume":"9","author":"M Dosani","year":"2017","unstructured":"Dosani\u00a0M, Schrader\u00a0KA, Nichol\u00a0A, Sun\u00a0S, Shenkier\u00a0T, Lohn\u00a0Z et\u00a0al (2017) Severe Late Toxicity After Adjuvant Breast Radiotherapy in a\u00a0Patient with a\u00a0Germline Ataxia Telangiectasia Mutated Gene: Future Treatment Decisions. Cureus 9(7):e1458 (Jul)","journal-title":"Cureus"},{"issue":"7","key":"2411_CR21","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.3390\/cancers16071417","volume":"16","author":"R Bensenane","year":"2024","unstructured":"Bensenane\u00a0R, Beddok\u00a0A, Lesueur\u00a0F, Fourquet\u00a0A, Warcoin\u00a0M, Le Mentec\u00a0M et\u00a0al (2024) Safety of the Breast Cancer Adjuvant Radiotherapy in Ataxia-Telangiectasia Mutated Variant Carriers. Cancers (basel) 16(7):1417 (Apr)","journal-title":"Cancers (basel)"},{"issue":"5","key":"2411_CR22","doi-asserted-by":"publisher","first-page":"331","DOI":"10.6004\/jnccn.2024.0035","volume":"22","author":"WJ Gradishar","year":"2024","unstructured":"Gradishar\u00a0WJ, Moran\u00a0MS, Abraham\u00a0J, Abramson\u00a0V, Aft\u00a0R, Agnese\u00a0D et\u00a0al (2024) Breast cancer, version 3.2024, NCCN clinical practice guidelines in oncology. J\u00a0Natl Compr Canc Netw 22(5):331\u2013357","journal-title":"J Natl Compr Canc Netw"},{"key":"2411_CR23","doi-asserted-by":"publisher","first-page":"102522","DOI":"10.1016\/j.ctrv.2023.102522","volume":"114","author":"E Blondeaux","year":"2023","unstructured":"Blondeaux\u00a0E, Arecco\u00a0L, Punie\u00a0K, Graffeo\u00a0R, Toss\u00a0A, De Angelis\u00a0C et\u00a0al (2023) Germline TP53 pathogenic variants and breast cancer: A\u00a0narrative review. Cancer Treat Rev 114:102522 (Mar)","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"2411_CR24","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1186\/s12935-021-02172-8","volume":"21","author":"M Moslemi","year":"2021","unstructured":"Moslemi\u00a0M, Vafaei\u00a0M, Khani\u00a0P, Soheili\u00a0M, Nedaeinia\u00a0R, Manian\u00a0M et\u00a0al (2021) The prevalence of ataxia telangiectasia mutated (ATM) variants in patients with breast cancer patients: a\u00a0systematic review and meta-analysis. Cancer Cell Int 21(1):474 (Sep)","journal-title":"Cancer Cell Int"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-025-02411-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-025-02411-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-025-02411-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:58:18Z","timestamp":1779890298000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-025-02411-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2411"],"URL":"https:\/\/doi.org\/10.1007\/s00066-025-02411-1","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,12]]},"assertion":[{"value":"18 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"P.\u00a0Loap, F.\u00a0Goudjil, L.\u00a0de Marzi, K.\u00a0Cao, R.\u00a0Dendale, and Y.\u00a0Kirova declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}